Target intelligence / Profile preview

Cytochrome P450 11β-hydroxylase (CYP11B1)

Target
CYP11B1
Molecular classification
Enzyme, Cytochrome P450 monooxygenase, Mitochondrial enzyme
01

Overview

Cytochrome P450 11β-hydroxylase is a mitochondrial enzyme encoded by the CYP11B1 gene. It catalyzes the hydroxylation at the carbon position 11β on steroid precursors—primarily converting 11-deoxycortisol into cortisol and deoxycorticosterone into corticosterone, which are essential steps in glucocorticoid biosynthesis. The enzyme is highly expressed in the zona fasciculata of the adrenal cortex. Its activity is regulated by adrenocorticotropic hormone (ACTH). Mutations or deficiencies lead to congenital adrenal hyperplasia with symptoms ranging from virilization to hypertension depending on mutation severity. While it shares homology with aldosterone synthase (CYP11B2), it does not produce aldosterone itself. Pharmacological inhibition—such as by metyrapone—is clinically relevant for diagnostic testing but carries risks related to impaired stress response due to reduced cortisol synthesis.

Other names
Steroid 11β-hydroxylase11β-hydroxylaseC11B1 (gene/protein symbol)H11b (in some species and literature)
02

Mechanism of action

Inhibition of CYP11B1 blocks conversion of 11-deoxycortisol to cortisol, reducing glucocorticoid synthesis and increasing precursor steroids; this is exploited diagnostically or potentially therapeutically in conditions like Cushing’s syndrome or CAH management

03

Biological functions

Steroid biosynthesis (specifically glucocorticoids such as cortisol and corticosterone)Hydroxylation of steroid precursors at the 11β positionAndrogen metabolismDetoxification and defense mechanisms in steroidogenic tissues
04

Disease associations

Congenital adrenal hyperplasia (CAH) due to CYP11B1 deficiency, leading to impaired cortisol synthesis and excess androgen productionHypertension, particularly in cases of primary hyperaldosteronism associated with gene polymorphisms or mutations affecting enzyme activity
05

Safety considerations

Inhibition can cause adrenal insufficiency/crisis due to lack of cortisol production.
06

Interacting drugs

Metyrapone (CYP11B1 inhibitor used diagnostically for adrenal function testing)
07

Biomarkers

Serum levels of 17α-hydroxyprogesterone21-deoxycortisoldeoxycorticosteroneelevated levels of 11-deoxycortisol are used as biomarkers for CYP11B1 deficiency/CAH diagnosis

Beyond the preview

Go deeper on Cytochrome P450 11β-hydroxylase (CYP11B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 11β-hydroxylase (CYP11B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call